Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR‐TKIs Resistance.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70037
- By:
- Publication type:
- Article
Works matching IS 17526981 AND DT 2024 AND VI 18 AND IP 12
Results: 10
1
2
Rapid Response to Penpulimab Combined With Anlotinib and Chemotherapy in a Thoracic SMARCA4‐UT Without PD‐L1 Expression: A Case Report and Review of Literature.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70036
- By:
- Publication type:
- Article
3
Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70035
- By:
- Publication type:
- Article
4
Prediction of Optimal Positive Airway Pressure in Chinese Patients With Obstructive Sleep Apnea.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70047
- By:
- Publication type:
- Article
5
Explainable Machine Learning Predictions for the Benefit From Chemotherapy in Advanced Non‐Small Cell Lung Cancer Without Available Targeted Mutations.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70044
- By:
- Publication type:
- Article
6
Causal Association Between Monounsaturated Fatty Acids and Lung Cancer: A Two‐Sample Mendelian Randomization Study.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70038
- By:
- Publication type:
- Article
7
Liver Function Biomarkers and Lung Cancer Risk: A Prospective Cohort Study in the UK Biobank.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70042
- By:
- Publication type:
- Article
8
Dramatic Response to Ensartinib in Metastatic Neuroendocrine Tumors With a Novel CEP44‐ALK Fusion: A Case Report and Literature Review.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70040
- By:
- Publication type:
- Article
9
Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.70041
- By:
- Publication type:
- Article
10
Issue Information.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 12, p. 1, doi. 10.1111/crj.13645
- Publication type:
- Article